Table 3 Summary of expression profiles for the overall cohort, followed by subgroup analysis for tumour specimens and benign specimens.
From: The mRNA expression of SATB1 and SATB2 in human breast cancer
| Â | Overall | Tumour | Benign |
|---|---|---|---|
SATB1 | Â | Â | Â |
Absolute | 78.7 (0–976.1, 15.0) | 88.6 (0–912.9, 24.5) | 51.1 (0–976.1, 7.0) |
Normalised | 0.80 (0–23.49, 0.19) | 0.74 (0–8.26, 0.20) | 0.41 (0–1.49, 0.22) |
SATB2 | Â | Â | Â |
Absolute | 48.1 (0–2104.2, 0.0) | 59.9(2104.2, 0.1) | 9.84 (0–213.07, 0.0) |
Normalised | 0.12 (0–2.09, 0) | 0.14 (0–2.09, 0) | 0.05 (0–0.54, 0) |